Marina Udier
Director/Board Member bei CELYAD ONCOLOGY SA
Profil
Marina Udier is currently the Chief Executive Officer & Director at Nouscom AG since 2020.
She is also the Chief Executive Officer & Director at Nouscom Srl.
Prior to her current positions, Dr. Udier served as an Independent Director at Celyad Oncology SA starting in 2011.
She has former experience as the Head-Global Commercial at Novartis AG and as the Chief Operating Officer at Versant Venture Management LLC.
Dr. Udier holds a doctorate degree from Yale University.
Aktive Positionen von Marina Udier
| Unternehmen | Position | Beginn |
|---|---|---|
| CELYAD ONCOLOGY SA | Director/Board Member | 11.01.2011 |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Chief Executive Officer | 01.05.2019 |
| Nouscom Srl | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Marina Udier
| Unternehmen | Position | Ende |
|---|---|---|
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Chief Operating Officer | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Ausbildung von Marina Udier
| Yale University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NOVARTIS AG | Health Technology |
| CELYAD ONCOLOGY SA | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Health Technology |
| Nouscom Srl | Commercial Services |
